Cell and Gene Therapies in $3.5M Study for Aging

A

Aubrey de Grey at Longevity Investors Conference 2024

Quotes From Source

The treatments involve cell therapies and gene therapies...

Story of claim

A study led by Aubrey de Grey combines cell and gene therapies with a $3.5M budget to reverse aging. Existing interventions are utilized, focusing on rejuvenation rather than slowing aging.

  • Goal: To rejuvenate individuals by reversing aging, not just slowing it down.
  • Proof: Combines novel interventions that don't alter metabolism but aim to remove aging-related damage.
  • Nuances:
    • $3 million paid upfront
    • Combining existing promising interventions
    • Doesn't generate significant IP
  • Impact on Life: Potential to significantly advance the field of anti-aging research.

Investments

  • Price: $3.5 million
  • Time: 18 months
  • Effort: High due to complexity and scale of research.

Risks

Financial risk due to high upfront investment without guaranteed IP returns.

Get Started 🚀

  • Secure funding for large-scale studies
  • Combine existing cell and gene therapies
  • Focus on interventions shown to remove aging damage

Brogevity AI can make mistakes. Check important info.


Reference Video